Clinical trial NCT04360746 - References

Hip Fractures — The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients

Citation(s)

•   Boparai MK, Korc-Grodzicki B
  Prescribing for older adults. Mt Sinai J Med. 2011 Jul-Aug;78(4):613-26. doi: 10.1002/msj.20278.
•   Bulloch MN, Olin JL
  Instruments for evaluating medication use and prescribing in older adults. J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):530-7. doi: 10.1331/JAPhA.2014.13244.
•   Cornu P, Steurbaut S, Leysen T, De Baere E, Ligneel C, Mets T, Dupont AG
  Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients. Ann Pharmacother. 2012 Apr;46(4):484-94. doi: 10.1345/aph.1Q594. Epub 2012 Mar 13.
•   Folstein MF, Folstein SE, McHugh PR
  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.
•   Geller AI, Nopkhun W, Dows-Martinez MN, Strasser DC
  Polypharmacy and the role of physical medicine and rehabilitation. PM R. 2012 Mar;4(3):198-219. doi: 10.1016/j.pmrj.2012.02.012.
•   Gillespie U, Alassaad A, Hammarlund-Udenaes M, Morlin C, Henrohn D, Bertilsson M, Melhus H
  Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial. PLoS One. 2013 May 17;8(5):e62401. doi: 10.1371/journal.pone.0062401. Print 2013.
•   Granger CV, Hamilton BB
  The Uniform Data System for Medical Rehabilitation report of first admissions for 1992. Am J Phys Med Rehabil. 1994 Feb;73(1):51-5. No abstract available.
•   Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR
  A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992 Oct;45(10):1045-51. doi: 10.1016/0895-4356(92)90144-c.
•   Heruti RJ, Lusky A, Barell V, Ohry A, Adunsky A
  Cognitive status at admission: does it affect the rehabilitation outcome of elderly patients with hip fracture? Arch Phys Med Rehabil. 1999 Apr;80(4):432-6. doi: 10.1016/s0003-9993(99)90281-2.
•   Iaboni A, Rawson K, Burkett C, Lenze EJ, Flint AJ
  Potentially Inappropriate Medications and the Time to Full Functional Recovery After Hip Fracture. Drugs Aging. 2017 Sep;34(9):723-728. doi: 10.1007/s40266-017-0482-6.
•   Kragh Ekstam A, Elmstahl S
  Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clin Interv Aging. 2016 Apr 29;11:489-96. doi: 10.2147/CIA.S101832. eCollection 2016.
•   Lee JK, Alshehri S, Kutbi HI, Martin JR
  Optimizing pharmacotherapy in elderly patients: the role of pharmacists. Integr Pharm Res Pract. 2015 Aug 11;4:101-111. doi: 10.2147/IPRP.S70404. eCollection 2015.
•   Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M
  Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013 Jul;61(7):1119-27. doi: 10.1111/jgs.12323. Epub 2013 Jun 24.
•   Ottenbacher KJ, Mann WC, Granger CV, Tomita M, Hurren D, Charvat B
  Inter-rater agreement and stability of functional assessment in the community-based elderly. Arch Phys Med Rehabil. 1994 Dec;75(12):1297-301.
•   Perez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T
  Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018 Nov 14;363:k4524. doi: 10.1136/bmj.k4524.
•   Rolland Y, Pillard F, Lauwers-Cances V, Busquere F, Vellas B, Lafont C
  Rehabilitation outcome of elderly patients with hip fracture and cognitive impairment. Disabil Rehabil. 2004 Apr 8;26(7):425-31. doi: 10.1080/09638280410001663148.
•   Salahudeen MS, Duffull SB, Nishtala PS
  Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015 Mar 25;15:31. doi: 10.1186/s12877-015-0029-9.
•   Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ
  A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994 Aug;47(8):891-6. doi: 10.1016/0895-4356(94)90192-9.
•   Somers A, Mallet L, van der Cammen T, Robays H, Petrovic M
  Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012 Apr;10(2):101-9. doi: 10.1016/j.amjopharm.2012.01.003. Epub 2012 Feb 1.
•   Spinewine A, Fialova D, Byrne S
  The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012 Jun 1;29(6):495-510. doi: 10.2165/11631720-000000000-00000.
•   Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT
  Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007 Jul 14;370(9582):173-184. doi: 10.1016/S0140-6736(07)61091-5.
•   Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, Tulkens PM
  Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007 May;55(5):658-65. doi: 10.1111/j.1532-5415.2007.01132.x.
•   Viktil KK, Blix HS
  The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):275-80. doi: 10.1111/j.1742-7843.2007.00206.x. Epub 2008 Jan 30.
•   Walsh KA, O'Riordan D, Kearney PM, Timmons S, Byrne S
  Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists' interventions in secondary care. Age Ageing. 2016 Mar;45(2):201-9. doi: 10.1093/ageing/afv190. Epub 2016 Jan 10.

The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients

Details for clinical trial NCT04360746